Menu

Scripps Faculty Wants President Out

Some faculty members of the Scripps Research Institute are wary of a possible merger with USC and would like to oust the organization’s president.

Jul 7, 2014
Kerry Grens

WIKIMEDIA, ELIFE SCIENCES PUBLICATIONS, LTDThe University of Southern California (USC) in Los Angeles and the Scripps Research Institute (TSRI) in La Jolla are discussing some form of partnership, and Scripps faculty members are not happy about it. U-T San Diego reported on Friday (July 4) that professors there have begun “an unprecedented faculty revolt” to oust Scripps’s president, Michael Marletta.

Last week, all of the institute’s department chairs and its dean sent a letter to the chair of the board of trustees expressing their lack of confidence in Marletta. At issue is a possible merger with or takeover by USC, which faculty members said they want dropped. Additionally, members have said that Marletta has not done enough to buoy Scripps’s sinking financial situation.

Marletta told U-T San Diego, “there are more than 250 faculty members at Scripps. It is impractical to involve every single one of them in a time-consuming and exhaustive review of options for the institute’s future.”

A partnership with USC may help the financially troubled TSRI, which is projecting a $21 million operating deficit this year. Peter Farrell, a Scripps trustee, said, “I can tell you categorically that what USC would like is for TSRI to not only keep what it's been doing, but to do it better. USC is in a position when it can provide plenty of resources.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.